The Wrinkle Power Filling is one of those cosmetic products that circulates abundantly on social media, presented as quick anti-wrinkle solutions. Before applying or purchasing it, one question deserves to be asked: what documented side effects are there, and how do they compare to medically supervised treatments?
Documented skin reactions by ANSM after injection of filler products
The National Agency for the Safety of Medicines and Health Products (ANSM) classifies the side effects of injectable wrinkle fillers according to their onset time. This table, derived from their public data, allows for measuring the potential severity of these reactions.
| Type of reaction | Onset time | Observed effects | Estimated duration |
|---|---|---|---|
| Immediate | 1 day – 15 days | Hematoma, erythema, edema | About 8 days |
| Semi-delayed | 15 days – 3 months | Infection, necrosis, non-specific inflammation | 1 to 6 months |
| Delayed | 3 – 24 months | Allergy, erythema, pigmentation | 1 to 12 months |
| Delayed (rare) | More than 3 months, sometimes several years | Granuloma | Several months to permanent |
According to the available data cited by the ANSM, the frequency of serious side effects is between 0.1 and 1% of patients. Slowly resorbable or non-resorbable products present an increased risk of granuloma, which can occur years after injection.
An analysis of more than 41,000 cases of hyaluronic acid injections, published in the Brussels Medical Review, estimates early serious complications (mainly vascular) at about 0.07%, or 7 cases per 10,000 injections. This rate remains low in a medically supervised context, but it assumes product traceability and practitioner training in managing complications.
To delve deeper into the risks of wrinkle power filling, it is necessary to distinguish between what falls under a supervised medical act and what falls under a free cosmetic application.
Wrinkle Power Filling sold online: legal framework and product traceability
In France, injectable devices based on hyaluronic acid intended for wrinkle filling can only be legally sold to doctors and dental surgeons. Their dispensing in pharmacies requires a medical prescription.
Any product presented as an “injectable filling” and sold freely online or in non-medical institutes falls outside this framework. This point is not trivial: it means that the cold chain, batch traceability, and compliance with European standards are not guaranteed.
Canada has also seized unapproved injectable products sold online, reminding that the lack of approval prevents any verification of the actual composition of the product. The same type of risk exists for purchases made from France on foreign platforms.
Difference between topical cosmetics and injectable devices
The term “filling” creates ambiguity. Some products bearing this name are creams or topical serums (applied to the skin), while others are injectables. The two categories are not subject to the same regulations.
- A topical serum containing peptides like acetyl hexapeptide-8 (Argireline) acts on the surface and falls under standard cosmetic regulation.
- An injectable based on hyaluronic acid is a class III medical device, subject to CE marking and reserved for healthcare professionals.
- A product sold as “filling” without specifying its route of administration may mislead about its true nature and usage precautions.
Active ingredients in anti-wrinkle serums: effectiveness and safety limits
Topical anti-wrinkle serums marketed under names similar to Wrinkle Power Filling generally contain actives with varying tolerance profiles.
The GHK-Cu peptide (copper peptide) is one of the frequently highlighted actives. Several specialized sources report that its prolonged use or high concentration can cause skin irritations, and it is not recommended for individuals with sensitivity to copper compounds. Long-term safety data remains limited.
Pro-Xylane, derived from xylose, is another common active in anti-wrinkle formulations. Its tolerance is generally good, but published studies focus on specific concentrations, not necessarily those used in non-standardized products.
Undesirable substances identified by Que Choisir
The comparison by Que Choisir on toxic substances in anti-wrinkle cosmetics lists several products classified as “at risk.” The highlighted ingredients include endocrine disruptors, allergens, and controversial preservatives.
- Some anti-wrinkle serums and creams contain UV filters suspected of endocrine activity.
- Preservatives like phenoxyethanol are present in formulations intended for the eye contour, a zone of thin and permeable skin.
- The absence of a readable INCI list on some products sold online prevents any independent verification of the composition.
Concrete precautions before using a filling-type anti-wrinkle product
The first reflex is to check whether the product is a topical cosmetic or an injectable. An injectable should never be used outside a medical office. If the product is sold without a prescription on a public site, it should not contain any injectable substance.
For a topical serum, the presence of a complete INCI list and a traceable batch number is a minimum. Databases like that of Que Choisir allow for cross-referencing the composition with known alerts on undesirable substances.
Individuals undergoing dermatological treatment, pregnant women, and those with a history of skin allergies should submit the ingredient list to a dermatologist before any use. Self-medication for anti-wrinkles with unverified products remains the main avoidable risk factor.
